5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Eli Lilly (LLY 1.80%) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...
Hosted on MSN23d
Eli Lilly in pact with Magnet Bio to develop cancer drugs in a deal worth up to $1.25B
Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to develop cancer drugs leveraging the company’s TrueGlue discovery platform.
BioSpace2d
J&J Joins Pharma Peers With $55B US Manufacturing Boost Following Trump’s Tariff Threats
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...
Eli Lilly: Growth With Higher Margins
Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...
Petri Dish: Biotech leaves Worcester; Novo Nordisk, Eli Lilly partnerships
One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...